During the past decade, Neurology Center of Las Vegas conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Neurology Center of Las Vegas" #1 sponsor was "ACADIA Pharmaceuticals Inc." with 2 trials, followed by "American Regent, Inc." with 2 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 2 trials sponsored, "Baxalta now part of Shire" with 1 trials sponsored and "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Neurology Center of Las Vegas" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Alzheimer's Association" with 1 trials as a collaborator, "Clinilabs, Inc." with 1 trials as a collaborator, "National Institute on Aging (NIA)" with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Neurology Center of Las Vegas" are "Multiple Sclerosis" (2 trials), "Restless Legs Syndrome (RLS)" (2 trials), "Alzheimer Disease" (1 trials), "Chronic Inflammatory Demyelinating Polyradiculoneuropathy" (1 trials) and "Dementia-related Psychosis" (1 trials). Many other conditions were trialed in "Neurology Center of Las Vegas" in a lesser frequency.

Most popular intervention types in "Neurology Center of Las Vegas" are "Drug" (7 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cladribine Tablets" (2 trials), "Placebo" (2 trials), "0.25% albumin placebo solution with rHuPH20" (1 trials), "15mg T3D-959" (1 trials) and "30 mg T3D-959" (1 trials). Other intervention names were less common.

The vast majority of trials in "Neurology Center of Las Vegas" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Neurology Center of Las Vegas". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Neurology Center of Las Vegas, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Neurology Center of Las Vegas, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".